Loading…
Based on limited metadata with no full letter text available, Kerry Inc received an FDA Warning Letter on July 26, 2018, regarding an unspecified product category classified as "Other." Without access to the detailed subject line or issuing office information, the specific nature of the violations cannot be determined from the available metadata. The regulatory scope and product-specific details would require review of the complete warning letter to accurately characterize the compliance issues cited by the FDA.